Amy L. Valderrama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amy L. Valderrama has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alec B. Chapman
University of Utah
1 shared publication - Barbara Ellen Jones
Division of Pulmonary & Critical Care Medicine, University of Utah and Salt Lake City VA Medical Center, Salt Lake City, UT
1 shared publication - Christine Yount
Centers for Disease Control and Prevention
1 shared publication - Daniel O. Scharfstein
University of Utah , School of Medicine, Department of Population Health Sciences, Division of Biostatistics; 295 Chipeta Way, Salt Lake City, UT 84108
1 shared publication Heather A. Moulton-Meissner
Centers for Disease Control and Prevention
1 shared publication- Jian Ying
University of Utah
1 shared publication
Latest Publications
- 13 October 2026
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- p. 1-7
Analysis of nontuberculous mycobacteria infection risks from CDC’s water-related healthcare outbreak consultations, 2018–2024
Objective: Nontuberculous mycobacteria (NTM) are commonly found in healthcare facility water systems and can lead to serious and difficult-to-treat infections. We analyzed Centers for Disease Control and Prevention (CDC) consultations of water-related healthcare-associated infections (HAI) investigations involving NTM. Design: Retrospective observational study. Methods: We searched CDC consultation records from January 1, 2018, through December 31, 2024, using water-related terms and organisms, excluding Legionella , to identify and review investigations involving potential or confirmed transmission of water-related organisms; we reviewed investigations that involved NTM. Results: Among 1,458 consultations, we identified 639 (43.8%) water-related investigations involving 4,685 patients and 60 different organisms. Investigations involving NTM accounted for 10.3% (n = 66) with 15 NTM species identified. Among NTM-related investigations, almost half involved M. abscessus (n = 31, 47.0%) and two-thirds (n = 44, 66.7%) involved extrapulmonary infections only. More than half of identified NTM investigations (n = 37, 56.1%) occurred in hospitals and over one-third (n = 23, 34.8%) in outpatient settings. Exposures to surgery (n = 27, 40.9%) and medical products (e.g., medical devices, medications, and biological products) (n = 35, 53.0%) were common. Conclusions: Over this seven-year period, approximately one-tenth of CDC healthcare water-related consultations involved NTM. The majority involved extrapulmonary infections, with surgery and exposure to contaminated medical products representing the most common exposures of concern. These findings highlight the potential for NTM infections when water-related healthcare exposures occur. Healthcare facilities are encouraged to identify the potential for exposure to nonsterile water during surgery, during the use of medical devices, and during the preparation and administration of medications to reduce the risk from NTM.
- 13 October 2026
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- p. 1-7
Analysis of nontuberculous mycobacteria infection risks from CDC’s water-related healthcare outbreak consultations, 2018–2024
Objective: Nontuberculous mycobacteria (NTM) are commonly found in healthcare facility water systems and can lead to serious and difficult-to-treat infections. We analyzed Centers for Disease Control and Prevention (CDC) consultations of water-related healthcare-associated infections (HAI) investigations involving NTM. Design: Retrospective observational study. Methods: We searched CDC consultation records from January 1, 2018, through December 31, 2024, using water-related terms and organisms, excluding Legionella , to identify and review investigations involving potential or confirmed transmission of water-related organisms; we reviewed investigations that involved NTM. Results: Among 1,458 consultations, we identified 639 (43.8%) water-related investigations involving 4,685 patients and 60 different organisms. Investigations involving NTM accounted for 10.3% (n = 66) with 15 NTM species identified. Among NTM-related investigations, almost half involved M. abscessus (n = 31, 47.0%) and two-thirds (n = 44, 66.7%) involved extrapulmonary infections only. More than half of identified NTM investigations (n = 37, 56.1%) occurred in hospitals and over one-third (n = 23, 34.8%) in outpatient settings. Exposures to surgery (n = 27, 40.9%) and medical products (e.g., medical devices, medications, and biological products) (n = 35, 53.0%) were common. Conclusions: Over this seven-year period, approximately one-tenth of CDC healthcare water-related consultations involved NTM. The majority involved extrapulmonary infections, with surgery and exposure to contaminated medical products representing the most common exposures of concern. These findings highlight the potential for NTM infections when water-related healthcare exposures occur. Healthcare facilities are encouraged to identify the potential for exposure to nonsterile water during surgery, during the use of medical devices, and during the preparation and administration of medications to reduce the risk from NTM.
- Open Access
- 15 October 2025
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 46 (12) , 1190-1198
Evaluating the impact of an oral care initiative on the risk of non-ventilator-associated hospital-acquired pneumonia using electronic clinical data and diagnostic coding surveillance criteria
Objective: We assessed the impact of an oral care initiative on non-ventilator-associated hospital-acquired pneumonia (NV-HAP) risk using two different measurement strategies. Methods: We evaluated changes in NV-HAP events among all patients admitted to 17 VA Medical Centers (1) across the period 10/01/2015–12/31/2019, and (2) one-year pre- vs post- each hospital’s oral care initiative start date. We modeled and compared observed versus predicted NV-HAP events per hospitalization using (1) an electronic clinical definition and (2) diagnosis codes, adjusting for patients’ demographics, vital signs, and laboratory results at presentation. Results: Among 333,257 hospitalizations, 1,922 (0.58%) met NV-HAP electronic clinical criteria and 2,386 (0.72%) diagnostic coding criteria. The risk of NV-HAP defined by electronic clinical criteria was 0.62% in October 2015 and 0.54% in December 2019 (estimated difference –0.084% [95% CI: –0.17%, 0.0056%]; the risk of NV-HAP defined by diagnostic coding decreased from 1.0% to 0.48% (estimated difference –0.53% [–0.63%, –0.43%]). In the one-year pre- vs post-analysis, there was no evidence of effect of the implementation on NV-HAP using either electronic clinical criteria (adjusted risk difference –0.078% (95% CI: –0.25%, 0.091%) or diagnostic coding criteria (adjusted risk difference –0.021% (95% CI: –0.18%, 0.14%). Conclusions: In a large multi-center study of hospitalized patients, we were unable to identify a clear effect of an oral care initiative on NV-HAP using electronic clinical criteria or diagnostic coding criteria.
- 15 October 2025
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 46 (12) , 1190-1198
Open AccessEvaluating the impact of an oral care initiative on the risk of non-ventilator-associated hospital-acquired pneumonia using electronic clinical data and diagnostic coding surveillance criteria
Objective: We assessed the impact of an oral care initiative on non-ventilator-associated hospital-acquired pneumonia (NV-HAP) risk using two different measurement strategies. Methods: We evaluated changes in NV-HAP events among all patients admitted to 17 VA Medical Centers (1) across the period 10/01/2015–12/31/2019, and (2) one-year pre- vs post- each hospital’s oral care initiative start date. We modeled and compared observed versus predicted NV-HAP events per hospitalization using (1) an electronic clinical definition and (2) diagnosis codes, adjusting for patients’ demographics, vital signs, and laboratory results at presentation. Results: Among 333,257 hospitalizations, 1,922 (0.58%) met NV-HAP electronic clinical criteria and 2,386 (0.72%) diagnostic coding criteria. The risk of NV-HAP defined by electronic clinical criteria was 0.62% in October 2015 and 0.54% in December 2019 (estimated difference –0.084% [95% CI: –0.17%, 0.0056%]; the risk of NV-HAP defined by diagnostic coding decreased from 1.0% to 0.48% (estimated difference –0.53% [–0.63%, –0.43%]). In the one-year pre- vs post-analysis, there was no evidence of effect of the implementation on NV-HAP using either electronic clinical criteria (adjusted risk difference –0.078% (95% CI: –0.25%, 0.091%) or diagnostic coding criteria (adjusted risk difference –0.021% (95% CI: –0.18%, 0.14%). Conclusions: In a large multi-center study of hospitalized patients, we were unable to identify a clear effect of an oral care initiative on NV-HAP using electronic clinical criteria or diagnostic coding criteria.